ImmuCell Corporation — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f25ea1d5-69f9-4684-8f91-b720788eaca3/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $27.6M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-010339 |
| FY 2024 | $26.5M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-034817 |
| FY 2023 | $17.5M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-042925 |
| FY 2022 | $18.6M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-086092 |
| FY 2021 | $19.2M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-074215 |
| FY 2020 | $15.3M | 2020-01-01 – 2020-12-31 | evidence 0001213900-22-074215 |
| FY 2019 | $13.7M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-007650 |
| FY 2018 | $11.0M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-004653 |
| FY 2017 | $10.4M | 2017-01-01 – 2017-12-31 | evidence 0001213900-19-004653 |
| FY 2016 | $9.5M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-003009 |
| FY 2015 | $10.2M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-011870 |
| FY 2014 | $7.6M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002097 |
| FY 2013 | $6.0M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-017813 |
| FY 2012 | $5.4M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-018264 |
| FY 2011 | $5.1M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-017287 |
| FY 2010 | $4.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-017287 |
| FY 2009 | $4.5M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-017287 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ImmuCell Corporation — all facts · Net Income · Operating Income